Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You and Your Team.

Learn More →

Practice Patterns and Outcomes of Novel Targeted Agents for the Treatment of ERBB2-Positive Metastatic Breast Cancer

Practice Patterns and Outcomes of Novel Targeted Agents for the Treatment of ERBB2-Positive... This cohort study describes practice patterns and outcomes associated with use of pertuzumab and trastuzumab emtansine in routine clinical practice. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Oncology American Medical Association

Practice Patterns and Outcomes of Novel Targeted Agents for the Treatment of ERBB2-Positive Metastatic Breast Cancer

Loading next page...
 
/lp/american-medical-association/practice-patterns-and-outcomes-of-novel-targeted-agents-for-the-LAzK0e0XRT
Publisher
American Medical Association
Copyright
Copyright 2021 American Medical Association. All Rights Reserved.
ISSN
2374-2437
eISSN
2374-2445
DOI
10.1001/jamaoncol.2021.2140
Publisher site
See Article on Publisher Site

Abstract

This cohort study describes practice patterns and outcomes associated with use of pertuzumab and trastuzumab emtansine in routine clinical practice.

Journal

JAMA OncologyAmerican Medical Association

Published: Sep 8, 2021

References